CCFZ533X2201 - PoC Study in de Novo Renal Transplantation

NCT02217410 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

BIOLOGICAL: CFZ533
DRUG: Tacrolimus (Tac)
DRUG: Mycophenolate mofetil (MMF)
DRUG: Corticosteroids (CS)
BIOLOGICAL: anti-IL2 Induction

Sponsor

Novartis Pharmaceuticals